🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Sarcopenia in Colorectal Cancer Patients, Intervention Study

RecruitingNAAges 70 Years - anyAllHospital Universitari de Bellvitge
NCT05491434 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The sarcopenia is a new concept for evaluating the functional status of patients, introduced during the last 20 years. This is defined as the relationship between the deterioration of muscle mass and the decrease in strength, the metabolic rate, the aerobic capacity and subsequently the evaluation of the functional status. The sarcopenia has been estimated to affect 5% to 13% of people aged between 60 and 70 years, increasing from 11% to 50% in those aged 80 years and older. In a study by Lieffers et al. of a total of 234 patients with colorectal cancer, with a mean age of 63 years according to the values observed by Prado et al., the prevalence of sarcopenia would be around 39%, being able to reach up to 60% in patients with chronic diseases. The goal of this study is to compare the cumulative incidence of post-surgical complications due to infection at 30 days between the group of pat

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 70 years old, * Colon adenocarcinoma without synchronous metàstasis, * No urgent surgery, * ECOG performance status ≤ 2, * no pregnancy or lactation, * signature of the informed consent, * ability to comply with the study indications. Exclusion Criteria: * rectal càncer, * Concomitant neoplastic disease in the last 5 years * medical or mental condition of the patient that compromises the authorization of informed consent, * Concomitant uncontrolled or stable medical condition, * Clinically significant heart disease (congestive heart failure, symptomatic coronary disease) * Refusal to participate in the study.
💊

What it tests

  • Protein supplement
📍

Where

1 site
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy